Trial Profile
Phase II Study to Assess the Safety, Imaging, Pharmacodynamic and Clinical Outcomes of Acute Ischemic Stroke Subjects Treated With tPA and THR-18
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs THR 18 (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Sponsors D-Pharm
- 16 Nov 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 14 Oct 2015 New trial record